| Net Cash Provided by (Used in) Operating Activities |
$2,828,000 |
USD |
-32% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$7,531,000 |
USD |
72% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$723,000 |
USD |
-103% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$5,426,000 |
USD |
-187% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$79,106,000 |
USD |
23% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$6,692,000 |
USD |
-30% |
Q1 2025 |
Q1 2025 |
| Depreciation |
$2,720,000 |
USD |
309% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$341,354,000 |
USD |
0.54% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$928,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Interest Expense |
$40,090,000 |
USD |
12% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |